Exagen started at buy with $25 stock price target at Canaccord Genuity

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Exagen Inc.

Exagen, Inc. is a commercial-stage diagnostics company. It engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. The company operates under the Avise brand. Exagen was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply